Bristol Myers Squibb
Community score
Incorporated in 1887, the company is headquartered in New York City, New York, United States, and operates in several key business categories including Oncology, Immunology, Cardiovascular, Fibrosis, and Hematology. The company's portfolio boasts significant brands such as Opdivo (nivolumab), Eliquis (apixaban), Revlimid (lenalidomide), Orencia (abatacept), and Pomalyst/Imnovid (pomalidomide). Bristol Myers Squibb has a robust global presence, with its products and services being significantly marketed in regions like the United States, Europe, Asia, and other areas around the world. The most important markets for the company encompass the United States, Japan, China, Germany, France, and Italy, among other nations. (Powered by AI)